These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9492387)
21. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs. Boothe DM; Perkins J J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278 [TBL] [Abstract][Full Text] [Related]
22. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. Taguchi K; Schäfers RF; Michel MC Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques. Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721 [TBL] [Abstract][Full Text] [Related]
24. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
25. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs. He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL). Michel MC; Chapple CR Eur Urol; 2006 Mar; 49(3):501-8; discussion 508-9. PubMed ID: 16442211 [TBL] [Abstract][Full Text] [Related]
27. Determination of tamsulosin in dog plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. Qi M; Wang P; Liu L J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):7-11. PubMed ID: 15113533 [TBL] [Abstract][Full Text] [Related]
28. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs. Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376 [TBL] [Abstract][Full Text] [Related]
29. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes. Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD Chirality; 1999; 11(3):233-40. PubMed ID: 10079502 [TBL] [Abstract][Full Text] [Related]
30. A review of the clinical pharmacokinetics and metabolism of the alpha 1-adrenoceptor antagonist indoramin. Pierce DM Xenobiotica; 1990 Dec; 20(12):1357-67. PubMed ID: 1981634 [TBL] [Abstract][Full Text] [Related]
31. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241 [TBL] [Abstract][Full Text] [Related]
32. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. Na YJ; Guo YL; Gu FL J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165 [TBL] [Abstract][Full Text] [Related]
33. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity. Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607 [TBL] [Abstract][Full Text] [Related]
34. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats. Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714 [TBL] [Abstract][Full Text] [Related]
35. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. Löscher W J Pharmacol Exp Ther; 1978 Feb; 204(2):255-61. PubMed ID: 340640 [TBL] [Abstract][Full Text] [Related]
36. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. Gu Y; Wang GJ; Sun JG; Jia YW; Wang W; Xu MJ; Lv T; Zheng YT; Sai Y Food Chem Toxicol; 2009 Sep; 47(9):2257-68. PubMed ID: 19524010 [TBL] [Abstract][Full Text] [Related]
38. Cross-species comparisons of the pharmacokinetics of ibudilast. Sanftner LM; Gibbons JA; Gross MI; Suzuki BM; Gaeta FC; Johnson KW Xenobiotica; 2009 Dec; 39(12):964-77. PubMed ID: 19925385 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs. Samara E; Bialer M Drug Metab Dispos; 1988; 16(6):875-9. PubMed ID: 2907468 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]